Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Journal of Women'S Health (2002)
|
April 29, 2005
Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy
Sheila G West, Kirsten F Hilpert, Vijaya Juturu, et al.
Geburtshilfe Und Frauenheilkunde
|
March 5, 2016
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer
P Harter, A du Bois, S Mahner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2016
Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO
M Klar, A Hasenburg, M Hasanov, et al.
Geburtshilfe Und Frauenheilkunde
|
October 10, 2014
Rare Benign Entities of the Breast - Myoid Hamartoma and Capillary Hemangioma
F K Schäfer, J Biernath-Wuepping, C Eckmann-Scholz, et al.
The American Journal of Medicine
|
February 5, 2003
Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer
Penny M Kris-Etherton, Kari D Hecker, Andrea Bonanome, et al.
Anticancer Research
|
August 5, 2010
Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer
D O Bauerschlag, M Habermann, J Weimer, et al.
European Journal of Radiology
|
March 3, 2012
Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome(®)-system 11 g/8 g vs. ATEC(®)-system 12 g/9 g
F K W Schaefer, B M Order, C Eckmann-Scholz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 29, 2006
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR
J Pfisterer, A du Bois, J Sehouli, et al.
Journal of the American College of Nutrition
|
October 16, 2009
Effects of dairy products on intracellular calcium and blood pressure in adults with essential hypertension
Kirsten F Hilpert, Sheila G West, Deborah M Bagshaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2017
Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy
F T Roncolato, E Gibbs, C K Lee, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Journal of Women'S Health (2002)
|
April 29, 2005
Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy
Sheila G West, Kirsten F Hilpert, Vijaya Juturu, et al.
Geburtshilfe Und Frauenheilkunde
|
March 5, 2016
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer
P Harter, A du Bois, S Mahner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2016
Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO
M Klar, A Hasenburg, M Hasanov, et al.
Geburtshilfe Und Frauenheilkunde
|
October 10, 2014
Rare Benign Entities of the Breast - Myoid Hamartoma and Capillary Hemangioma
F K Schäfer, J Biernath-Wuepping, C Eckmann-Scholz, et al.
The American Journal of Medicine
|
February 5, 2003
Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer
Penny M Kris-Etherton, Kari D Hecker, Andrea Bonanome, et al.
Anticancer Research
|
August 5, 2010
Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer
D O Bauerschlag, M Habermann, J Weimer, et al.
European Journal of Radiology
|
March 3, 2012
Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome(®)-system 11 g/8 g vs. ATEC(®)-system 12 g/9 g
F K W Schaefer, B M Order, C Eckmann-Scholz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 29, 2006
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR
J Pfisterer, A du Bois, J Sehouli, et al.
Journal of the American College of Nutrition
|
October 16, 2009
Effects of dairy products on intracellular calcium and blood pressure in adults with essential hypertension
Kirsten F Hilpert, Sheila G West, Deborah M Bagshaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2017
Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy
F T Roncolato, E Gibbs, C K Lee, et al.
Page
of 4